{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2015"],"data_sharing_plan":["IPD Sharing (as of February 2022): No"],"condition":["Colorectal Cancer","Colorectal Neoplasms"],"disease":["Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2184768"],"location":["United States"],"study_start_month":["5"],"keyword":["Pembrolizumab","MK-3475"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer","description":"This is a multi-institutional, single arm, open-label, phase II study, including a safety run-in cohort. No randomization or blinding involved.","dates":{"creation":"2015-05-15"},"accession":"2184768","cross_references":{"ClinicalTrials___gov":["NCT02375672"]}}